CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 74 filers reported holding CASI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $240,000 | -18.6% | 100,091 | 0.0% | 0.00% | – |
| Q4 2020 | $295,000 | +147.9% | 100,091 | +28.8% | 0.00% | – |
| Q3 2020 | $119,000 | -38.3% | 77,725 | +0.5% | 0.00% | – |
| Q2 2020 | $193,000 | +22.2% | 77,304 | 0.0% | 0.00% | – |
| Q1 2020 | $158,000 | -33.1% | 77,304 | +1.2% | 0.00% | – |
| Q4 2019 | $236,000 | -7.5% | 76,406 | 0.0% | 0.00% | – |
| Q3 2019 | $255,000 | +4.5% | 76,406 | 0.0% | 0.00% | – |
| Q2 2019 | $244,000 | +11.4% | 76,406 | 0.0% | 0.00% | – |
| Q1 2019 | $219,000 | -35.2% | 76,406 | -9.1% | 0.00% | -100.0% |
| Q4 2018 | $338,000 | -5.3% | 84,054 | +10.1% | 0.00% | 0.0% |
| Q3 2018 | $357,000 | -43.2% | 76,371 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $629,000 | – | 76,371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |